213 related articles for article (PubMed ID: 21219429)
1. The consequences of complacency: managing the effects of unrecognized Charcot feet.
Wukich DK; Sung W; Wipf SA; Armstrong DG
Diabet Med; 2011 Feb; 28(2):195-8. PubMed ID: 21219429
[TBL] [Abstract][Full Text] [Related]
2. Diabetic charcot neuroarthropathy of the hand: clinical course, diagnosis, and treatment options.
Illgner U; van Netten J; Droste C; Meiners T; Postema K; Wetz HH
Diabetes Care; 2014; 37(5):e91-2. PubMed ID: 24757250
[No Abstract] [Full Text] [Related]
3. [Early development of Charcot neuroarthropathy in the course of compensated diabetes mellitus--case report].
Kamińska A; Kamiński M; Jesionka P; Szymkowiak E; Bronisz A; Zmudzińska M; Junik R; Sikorska Z
Pol Arch Med Wewn; 2004 Jun; 111(6):709-13. PubMed ID: 15508794
[TBL] [Abstract][Full Text] [Related]
4. Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients.
Renner N; Wirth SH; Osterhoff G; Böni T; Berli M
BMC Musculoskelet Disord; 2016 Dec; 17(1):504. PubMed ID: 28031030
[TBL] [Abstract][Full Text] [Related]
5. Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis.
Grear BJ; Rabinovich A; Brodsky JW
Foot Ankle Int; 2013 Nov; 34(11):1541-7. PubMed ID: 23900228
[TBL] [Abstract][Full Text] [Related]
6. Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy.
Dallimore SM; Puli N; Kim D; Kaminski MR
J Foot Ankle Res; 2020 Sep; 13(1):56. PubMed ID: 32928270
[TBL] [Abstract][Full Text] [Related]
7. [Mid-Term Outcomes of Reconstruction of Charcot Foot Neuroarthropathy in Diabetic Patients].
Kučera T; Grinac M; Valtr O; Šponer P
Acta Chir Orthop Traumatol Cech; 2019; 86(1):51-57. PubMed ID: 30843514
[TBL] [Abstract][Full Text] [Related]
8. Radiographic measures as a predictor of ulcer formation in diabetic charcot midfoot.
Bevan WP; Tomlinson MP
Foot Ankle Int; 2008 Jun; 29(6):568-73. PubMed ID: 18549751
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
[TBL] [Abstract][Full Text] [Related]
10. Management of midfoot diabetic neuroarthropathy.
Myerson MS; Henderson MR; Saxby T; Short KW
Foot Ankle Int; 1994 May; 15(5):233-41. PubMed ID: 7951961
[TBL] [Abstract][Full Text] [Related]
11. Diabetic charcot neuroarthropathy: prevalence, demographics and outcome in a regional referral centre.
O'Loughlin A; Kellegher E; McCusker C; Canavan R
Ir J Med Sci; 2017 Feb; 186(1):151-156. PubMed ID: 27714504
[TBL] [Abstract][Full Text] [Related]
12. Charcot neuroarthropathy of the foot and ankle.
Schon LC; Easley ME; Weinfeld SB
Clin Orthop Relat Res; 1998 Apr; (349):116-31. PubMed ID: 9584374
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Diabetic Charcot Patients With and Without Foot Wounds.
Wukich DK; Sadoskas D; Vaudreuil NJ; Fourman M
Foot Ankle Int; 2017 Feb; 38(2):140-148. PubMed ID: 27923212
[TBL] [Abstract][Full Text] [Related]
14. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Scoring System for Patients Undergoing Reconstructive Foot and Ankle Surgery for Charcot Neuroarthropathy: The Charcot Reconstruction Preoperative Prognostic Score.
Rettedal D; Parker A; Popchak A; Burns PR
J Foot Ankle Surg; 2018; 57(3):451-455. PubMed ID: 29574036
[TBL] [Abstract][Full Text] [Related]
16. Charcot Neuroarthropathy. Recognize and refer quickly to prevent foot amputation.
Jackson K
Adv NPs PAs; 2011 Feb; 2(2):35-6. PubMed ID: 25693273
[No Abstract] [Full Text] [Related]
17. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
[TBL] [Abstract][Full Text] [Related]
18. Charcot neuroarthropathy triggered and complicated by osteomyelitis. How limb salvage can be achieved.
Aragón-Sánchez J; Lázaro-Martínez JL; Quintana-Marrero Y; Álvaro-Afonso FJ; Hernández-Herrero MJ
Diabet Med; 2013 Jun; 30(6):e229-32. PubMed ID: 23590722
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
[TBL] [Abstract][Full Text] [Related]
20. Results of Simple Conservative Treatment of Midfoot Charcot Arthropathy.
Kim YK; Lee HS; Seo SG; Park SH; Boedijono D
Clin Orthop Surg; 2019 Dec; 11(4):459-465. PubMed ID: 31788170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
